Search Results
Site Search
Skip to Content MayoACCESS MayoLINK Register My Dashboard...
Neuro-Oncology Testing - Mayo Clinic Laboratories
At Mayo Clinic, we offer a comprehensive approach to neuro-oncology testing that focuses on the best outcomes for the patient
Communiqué takes a deep dive into how Mayo Clinic Laboratories advances patient care, research, and education through laboratory medicine. Our experts are solving the most serious and complex medical challenges for patients worldwide.
Mitochondrial disease - Insights
Learn about our four molecular testing options, which can be used to confirm a diagnosis and identify a specific mitochondrial syndrome.
Take a deeper look at the care provided to laboratory testing specimens along their meticulous journey through Mayo Clinic Laboratories testing.
Our suite of preeclampsia, prenatal, breast and gynecological cancer, and other testing has been developed in collaboration with clinical leaders in a variety of women’s health specialties to provide accurate, actionable results.
Respiratory viruses - Insights
Browse our full suite of serology and PCR testing for respiratory viruses like influenza, RSV, and more.
Subspecialty testing - Insights
Check out Mayo Clinic Laboratories’ comprehensive selection of pathology testing, which can guide diagnosis of malignancies and other diseases.
Check out how Mayo Clinic Laboratories’ digital pathology initiative integrates digital infrastructure to deliver digital workflows for patients to improve overall care.
Liquid biopsy offers noninvasive DNA testing for cancer care - Insights
Gang Zheng, M.D., Ph.D., and Aaron Mansfield, M.D., describe Mayo Clinic Laboratories’ liquid biopsy, which analyzes blood samples for genetic information to guide cancer treatment. The circulating tumor DNA assay uses next generation...
See how our innovative evaluations detect multiple sclerosis with increased sensitivity to put patients on the correct diagnostic pathway.
Learn more about how Mayo Clinic Laboratories’ unique testing for sphingolipidoses, including Gaucher and Krabbe diseases, can confirm diagnosis and guide disease management.
The National Kidney Foundation, the American Society for Clinical Pathology, and the nation’s leading laboratories and clinical laboratory societies have announced a new collaboration to remove barriers to testing for chronic kidney...
Membranous nephropathy - Insights
Membranous nephropathy (MN) is one of the leading causes of nephrotic syndrome in adults. Our menu of clinically validated assays assists with diagnosis, monitors disease progression, and guides clinical outcomes.
Urine supersaturation testing - Insights
Find out how our kidney stone testing services can predict the likely composition of stones in patients for whom stone analysis is not available.
Learn more Mayo Clinic Laboratories robust menu of newborn screening testing, which includes both primary and second-tier biochemical and molecular evaluations.
Ceramides are lipids associated with atherosclerotic plaque formation, hypertension, insulin resistance, and obesity. Mayo Clinic Laboratories’ testing quantifies ceramides, providing an early indicator to help physicians predict heart...
Mayo Clinic Research Advances Diagnostics to Lead COVID-19 Pandemic Response - Insights
When COVID-19 spread across the U.S. in early March, Mayo Clinic’s Advanced Diagnostic Laboratory urgently responded.
One Test, Multiple Targets: Zeroing in on Autoimmune Movement Disorders - Insights
A movement disorder might be caused by the body’s immune system, which is meant to fight infections, suddenly attacking the brain. Fortunately, an “autoimmune movement disorder” can often be treated—once its cause is discovered.
Mayo Clinic Laboratory and Pathology Research Roundup: Jan. 8 - Insights
This week’s Research Roundup highlights how cardiac troponin is released from injured myocardium.
Key performance indicators for laboratory outreach programs - Insights
Key performance indicators (KPIs) should be a part of every laboratory’s quality improvement plan, and that includes outreach-specific KPI metrics. Financial, internal-facing, and client-facing KPIs for outreach programs help to create a...
Week in Review: April 1 - Insights
Today's Highlights Include: Walz signs ALS bill by senator with the disease, Health Fusion: A farm family's journey from tragedy to gratefulness through organ donation, and google Search will soon let you book checkups and other medical...
Cardiovascular Events in Patients With or Without Coronary Artery Disease
A new type of blood test may help physicians identify which patients with and without evidence of coronary blockages are at risk for heart attacks and strokes. Even individuals with normal levels of low-density lipoprotein (LDL), known as...
Mayo Clinic Laboratories has launched a first-in-the-U.S. autoimmune test of the Kelchlike protein 11 antibody, or KLHL11, which is used to detect autoimmune disease associated with testicular cancer.
Beyond the test result Mayo Clinic Laboratories combines the expertise of world-renowned laboratorians and physicians to provide answers for patients’
Rare Lyme disease-causing bacteria spotted on routine blood films - Insights
It’s been understood for some time that an infection of B. mayonii, a rare species of bacterium, results in high levels of spirochetes in the peripheral blood. But actually being able to visualize them on a routine peripheral blood smear...
Testing Archives - Page 3 of 26 - Insights
Skip to Content MayoACCESS MayoLINK Register My Dashboard...
NGS Testing for Neuro-Oncology - Mayo Clinic Laboratories
Mayo Clinic is recognized worldwide for providing care for complex diseases including brain tumors. With rapid technological advancements and medical discoveries, the standard approach to genetic testing is evolving.
Five Steps to Manage Change in an Outreach Laboratory - Insights
When introducing a new initiative in the medical laboratory environment, effective change management is essential.
The Value Stream of an Outreach Program - Insights
When considering the outreach laboratory value stream, it is important to remember that without quality, there is no value. Through identifying sources for error or non-value-added activities, the hospital laboratory outreach program can...
What the Patient Considers When Choosing a Laboratory - Insights
Patients want to use a laboratory that is easy to work with, and there are different definitions of “easy.” Ultimately, health systems want to have the patients they serve use their health system laboratories. If patients are choosing to go...
New tests launched in February - Insights
In February 2022, Mayo Clinic Laboratories announced fourteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Solutions for Common Service Recovery Challenges - Insights
Despite our best efforts, customer service failures do happen, but good service recovery tools can turn failures into positive customer experiences.
Leveraging the Laboratory - Insights
A Mayo Clinic podcast for administrators, outreach managers, and laboratory professionals hosted by Jane Hermansen, outreach manager at Mayo Clinic Laboratories, on how to best leverage and optimize the laboratory for patients, clients, and...
Plasma-Cell Neoplasms - Mayo Clinic Laboratories
As a pioneer in the field, Mayo Clinic plays an integral role by developing new tests to help align patients with new therapies for plasma cell disorders.
Dr. Morice Shares Trends and Predictions for 2025 - Insights
The healthcare and diagnostics landscape is poised for transformative changes driven by technological advancements and evolving market dynamics.
Colorectal panel provides detailed cancer information - Insights
Rondell Graham, M.B.B.S., describes Mayo Clinic Laboratories' new colorectal cancer panel. The assay covers more genes to better inform decision-making about prognosis, targeted therapies and a hereditary cancer syndrome.
Stiff-Person/PERM Evaluation - Insights
Andrew McKeon, M.B., B.Ch., M.D., explains how Mayo Clinic Laboratories' stiff-person assay provides comprehensive evaluation for individuals on the spectrum of stiff-person syndrome. In addition to guiding treatment decisions, the assay...
Hot Topic Archives - Page 4 of 5 - Insights
Skip to Content MayoACCESS MayoLINK Register My Dashboard...
TPNUQ genotyping assay - Insights
Ann Moyer, M.D., Ph.D., discusses TPNUQ, Mayo Clinic Laboratories' genotyping test for identifying patients at risk for thiopurine toxicity. Used prior to therapy initiation, our assay evaluates for nuances in both TPMT and NUDT15, which...
Due to a pending winter storm affecting the FedEx hub in Memphis, Tennessee, and the UPS hub in Louisville, Kentucky, Mayo Clinic Laboratories will monitor and track the situation with our logistics partners to minimize challenges. Read...
5 Steps to Improve Communication in Laboratory Outreach - Insights
Communication is a critical component of success. Laboratory outreach leaders can foster truly effective communication with five simple steps.
Rapid response: COVID-19, monkeypox, and whatever comes next - Insights
Mayo Clinic Laboratories' rapid response to public health threats has been honed during outbreaks of viruses like 2009’s H1N1 influenza, Zika, Ebola and, most recently, COVID-19. Before COVID-19, laboratory staff were already experts in...
Whole genome sequencing streamlines diagnosis - Insights
Nicole Boczek, Ph.D., and Sarah Barnett, M.S., CGC, explain how Mayo Clinic Laboratories' whole genome sequencing provides comprehensive information for rapid diagnosis of hereditary disorders.
Autoimmune Axonal Evaluation - Insights
Div Dubey, M.B.B.S., explains Mayo Clinic Laboratories' phenotypic testing approach for autoimmune axonal neuropathy. The comprehensive, serologic panel detects for antibodies with clinical relevance to the disease to provide clarity on...
Focused Pharmacogenomics Panel [Test in Focus] - Insights
Ann Moyer, M.D., Ph.D., explains Mayo Clinic Labs’ new focused pharmacogenomics panel, a real-time, PCR-based testing approach that assesses 10 genes known for their drug-gene associations, to provide guidance on medication selection for...
Breast cancer panel halves turnaround time: Wei Shen, Ph.D. - Insights
In this test-specific episode of the "Answers From the Lab" podcast, Wei Shen, Ph.D., explains how Mayo Clinic Laboratories' new breast cancer panel provides rapid results to guide critical decisions about treatment and screening.
A Test in Focus Archives - Page 5 of 11 - Insights
Skip to Content MayoACCESS MayoLINK Register My Dashboard...
Testing Archives - Page 2 of 26 - Insights
Skip to Content MayoACCESS MayoLINK Register My Dashboard...
Testing Archives - Page 4 of 26 - Insights
Skip to Content MayoACCESS MayoLINK Register My Dashboard...